21 May 2013
Keywords: fda, approves, par, pharma, megace, weight-loss, disorders
Article | 18 July 2005
The US Food and Drug Administration has approved Par Pharmaceuticals' Megace ES (megestrol acetate) for the treatment of anorexia, cachexia ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
20 May 2013
© 2013 thepharmaletter.com